4th Annual Biomarker and Companion Diagnostics Conference

7th-8th February 2019 | The Westin San Diego Gaslamp Quarter 910 Broadway Cir, San Diego, CA 92101, USA
CONFERENCE SPEAKERS
Advisors
Steve Richards
Steve Richards
Investigator, Biomarker Expert ,
Novartis



Katherine Call
Katherine Call
Head, Proteogenomics ,
Genzyme Sanofi



Speakers
James McDuffie
James McDuffie
Scientific Director ,
Janssen Research & Development



Sarah Wang
Sarah Wang
Director of Bioinformatics and Data Science ,
CareDx



Bianca Heinrich
Bianca Heinrich
Senior Scientist ,
AbCam



Timothy Tak-Chun
Timothy Tak-Chun
Senior Medical Science Director,
ACT Genomics



John Todd
John Todd
Senior Vice President and Chief Scientific Officer ,
Singulex



Catherine Sanders
Catherine Sanders
Senior Director, Research and Business Development ,
Adaptive Biotechnologies



Zhen Mahoney
Zhen Mahoney
Head, Business Development ,
Asuragen



Rolf Muller
Rolf Muller
CEO ,
BioFluidica



Thomas Briggs
Thomas Briggs
Senior Key Account and Business Development Manager ,
Becton Dickinson



Ken Bloom
Ken Bloom
Chief Medical Officer ,
Ambry Genetics



Will Westra
Will Westra
Senior Director of Business Development,
Oxford BioDynamics



Jeff Miller
Jeff Miller
CEO, CSO ,
Invivoscribe



Adil Daud
Adil Daud
Clinical Professor ,
UCSF



Steve Richards
Steve Richards
Investigator, Biomarker Expert ,
Novartis



Paul Wood
Paul Wood
Director, Metabolomics Unit, Professor, Associate Dean of Research ,
Lincoln Memorial University



Mark Ma
Mark Ma
Head, Bioanalytical and Biomarker Development ,
Alexion Pharmaceuticals



Qihong Huang
Qihong Huang
Senior Principal Scientist ,
Boehringer Ingelheim



Julianne Smith
Julianne Smith
Head, Translational Medicine ,
Cellectis



Joshua LaBaer
Joshua LaBaer
Director, Executive Director and Professor ,
University of Arizona



Jaya Goyal
Jaya Goyal
Vice President, Bioanalytical, Pharmacology and Biomarker Development ,
Wave Lifesciences



Mike Baratta
Mike Baratta
Scientific Director, Translational Biomarker Research ,
Takeda



Iman Jilani
Iman Jilani
Director, Oncology Clinical Assay Group ,
Pfizer



Howard Federoff
Howard Federoff
Professor of Neurology ,
University of California



John Rossi
John Rossi
Director, Translational Sciences ,
Kite Pharma


John joined Kite in February 2015 and is currently a Senior Director in the Department of Translational Medicine. John leads the Cell Therapy Clinical Pharmacology group and also supports or leads biomarker activities related to clinical development of Kite’s CAR T-cell pipeline. At Kite, John has led the development of a biomarker strategy and has also built an effective translational team to support the clinical development of axicabtagene ciloleucel/KTE-C19 and KTE-X19. During this time, John’s team has contributed directly to the US and European approval of axicabtagene ciloleucel through pharmacokinetic and pharmacodynamic evaluation of this product. Among many achievements at Kite, John has represented Kite through external scientific presentations and collaborative manuscripts with leading academic researchers such as Dr. Steven Rosenberg and Dr. James Kochenderfer at the National Cancer Institute. Scientific accomplishments include the discovery of novel metrics to characterize CAR T cells based on their functionality, novel biomarker knowledge of how CAR T cells work in the clinic, mechanistic information on CAR-related toxicities, novel insights into the biology of the tumor immune microenvironment, including immune checkpoints, and the pivotal role of IL-15 in the context of CAR T-cell function.


Pallavi Sachdev
Pallavi Sachdev
Senior Director, Clinical Pharmacology and Translational Medicine ,
Eisai



Katherine Call
Katherine Call
Head, Proteogenomics ,
Genzyme Sanofi